With a new strategic plan in place much of the attention from CareArc leadership in the new year will be placed on the continued construction and eventual opening of the health center’s new in-house pharmacy.
That was the report from CareArc CEO Renee Hively following the health center board of director’s monthly meeting Tuesday afternoon where members approved the new plan unanimously. Based on current plans, Hively says the pharmacy, set to be located on the northeast side of the facility, is expected to open in late 2025, September to be exact, and once it is opened will bring several benefits to patients including ease of access and reduced costs for medication and prescriptions thanks to the health center’s 340 B drug program.
Hively mentioned the health center does have additional 340 B partners in WalMart and Walgreens, however, the program with Graves was different and since its closure costs have, in some cases, tripled for their patients. She says the in-house pharmacy will help to fill the void left by Graves and hopefully reduce some of the costs to patients in years to come.
In addition to the review and approval of the strategic plan, board members also focused some of their attention on the center’s succession plan for the CEO role. Hively would clarify with KVOE News Tuesday that the succession plan is one of many policies updated on an annual basis by CareArc policy and not due to any pending changes in leadership.
Tuesday’s meeting also included a look at the monthly financial report which showed a $100,000 net gain for the health center which outpaced the estimated net gain of $8,000. Excluding federal grant funding for operational expenditures and equipment purchases, the health center currently reports a year-to-date net gain of $342,000.
The CareArc Board of Directors will reconvene for their monthly meeting in January.
